Biopharmx (BPMX) Stock Price, News & Analysis

Company Overview

BioPharmX Corporation was a specialty pharmaceutical company focused on developing and commercializing topical therapies for dermatological conditions. Its product candidates were designed to address acne, rosacea and other skin disorders using proprietary topical drug-delivery technology.

The company’s lead programs included BPX-01, a topical minocycline formulation intended to treat moderate-to-severe acne vulgaris, and BPX-04, a related topical treatment candidate for rosacea. BioPharmX also developed Invisicare, a topical delivery platform intended to improve the application and performance of pharmaceutical ingredients on the skin.

BioPharmX was based in the United States and operated primarily as a development-stage pharmaceutical company. Publicly available information about its later operations, current leadership and commercial activities is limited, and the company’s historical securities listing may no longer reflect an active standalone business under the BioPharmX name.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 336,508 shs
• Average Volume: 2.15 million shs
• Market Capitalization: $111.86 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 12/10/2019
• Today: 10/12/2026

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: NYSEAMERICAN:BPMX
• Previous Symbol: NYSE:BPMX
• CIK: N/A
• Web: www.biopharmx.com
• Phone: +1-650-8895020
• Fax: N/A
• Employees: 17
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 18,278,000
• Free Float: N/A
• Market Cap: $111.86 million
• Optionable: Not Optionable
• Beta: N/A